In Vivo Selection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2012-11, Vol.56 (11), p.6019-6020 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 6020 |
|---|---|
| container_issue | 11 |
| container_start_page | 6019 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 56 |
| creator | CARMAN, Robert J BOONE, James H GROVER, Harish WICKHAM, Kimberly N LI CHEN |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.00974-12 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_highwire_asm_aac_56_11_6019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1113211993</sourcerecordid><originalsourceid>FETCH-LOGICAL-a475t-33adea5c12026a6cdf66236a2418fcbd8a8d7e9df19637f8170bd6e596bf49d23</originalsourceid><addsrcrecordid>eNp1kc2LFDEQxYMo7rp68yyNICjYa5LupDsXYRj8WFgQ1lWPoSYfM7V0J2PSvTr_vdmdcdWDp1DkV-9V1SPkKaOnjPH-zWKxPKVUdW3N-D1yzKjqaymUvE-OKZWybnvaHpFHOV_RUgtFH5IjzhXtWSeOybezUH3F61h9doMzE8ZQRV9doIdxZzDUFy5jniBM1XKIeUpocR4ri96jwcFVdk4Y1rcNP3HEUF1uXILt7jF54GHI7snhPSFf3r-7XH6szz99OFsuzmtoOzHVTQPWgTCMUy5BGuul5I0E3rLem5XtobedU9YzJZvOl5npykpX1lv5VlnenJC3e93tvBqdNS5MCQa9TThC2ukIqP_9CbjR63itm7aXou-KwMuDQIrfZ5cnPWI2bhgguDhnzRhrOGNKNQV9vUdNijkn5-9sGNU3WeiShb7NQrOb0V7tccgj11dxTqFc4n_ss7_XuBP-HVQBXhwAyAYGnyAYzH84KVohWlq453tug-vND0xOF3cNYLSQxVdLylTzC1VxqsQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1113211993</pqid></control><display><type>article</type><title>In Vivo Selection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>CARMAN, Robert J ; BOONE, James H ; GROVER, Harish ; WICKHAM, Kimberly N ; LI CHEN</creator><creatorcontrib>CARMAN, Robert J ; BOONE, James H ; GROVER, Harish ; WICKHAM, Kimberly N ; LI CHEN</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00974-12</identifier><identifier>PMID: 22908175</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Aged ; Anti-Bacterial Agents ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial Proteins ; Bacterial Proteins - genetics ; Bacterial Proteins - metabolism ; Biological and medical sciences ; Clostridium difficile ; Clostridium difficile - drug effects ; Clostridium difficile - genetics ; Clostridium difficile - pathogenicity ; Drug Resistance, Bacterial ; Drug Resistance, Bacterial - drug effects ; Drug Resistance, Bacterial - genetics ; Enterocolitis, Pseudomembranous - drug therapy ; Enterocolitis, Pseudomembranous - microbiology ; Epidemiology and Surveillance ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Male ; Medical sciences ; Microbial Sensitivity Tests ; Other diseases. Semiology ; Pharmacology. Drug treatments ; Polymorphism, Single Nucleotide ; Rifamycins ; Rifamycins - pharmacology ; Rifamycins - therapeutic use ; Selection, Genetic ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.6019-6020</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved. 2012 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a475t-33adea5c12026a6cdf66236a2418fcbd8a8d7e9df19637f8170bd6e596bf49d23</citedby><cites>FETCH-LOGICAL-a475t-33adea5c12026a6cdf66236a2418fcbd8a8d7e9df19637f8170bd6e596bf49d23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486587/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486587/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26545540$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22908175$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CARMAN, Robert J</creatorcontrib><creatorcontrib>BOONE, James H</creatorcontrib><creatorcontrib>GROVER, Harish</creatorcontrib><creatorcontrib>WICKHAM, Kimberly N</creatorcontrib><creatorcontrib>LI CHEN</creatorcontrib><title>In Vivo Selection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Aged</subject><subject>Anti-Bacterial Agents</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial Proteins</subject><subject>Bacterial Proteins - genetics</subject><subject>Bacterial Proteins - metabolism</subject><subject>Biological and medical sciences</subject><subject>Clostridium difficile</subject><subject>Clostridium difficile - drug effects</subject><subject>Clostridium difficile - genetics</subject><subject>Clostridium difficile - pathogenicity</subject><subject>Drug Resistance, Bacterial</subject><subject>Drug Resistance, Bacterial - drug effects</subject><subject>Drug Resistance, Bacterial - genetics</subject><subject>Enterocolitis, Pseudomembranous - drug therapy</subject><subject>Enterocolitis, Pseudomembranous - microbiology</subject><subject>Epidemiology and Surveillance</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Other diseases. Semiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Rifamycins</subject><subject>Rifamycins - pharmacology</subject><subject>Rifamycins - therapeutic use</subject><subject>Selection, Genetic</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc2LFDEQxYMo7rp68yyNICjYa5LupDsXYRj8WFgQ1lWPoSYfM7V0J2PSvTr_vdmdcdWDp1DkV-9V1SPkKaOnjPH-zWKxPKVUdW3N-D1yzKjqaymUvE-OKZWybnvaHpFHOV_RUgtFH5IjzhXtWSeOybezUH3F61h9doMzE8ZQRV9doIdxZzDUFy5jniBM1XKIeUpocR4ri96jwcFVdk4Y1rcNP3HEUF1uXILt7jF54GHI7snhPSFf3r-7XH6szz99OFsuzmtoOzHVTQPWgTCMUy5BGuul5I0E3rLem5XtobedU9YzJZvOl5npykpX1lv5VlnenJC3e93tvBqdNS5MCQa9TThC2ukIqP_9CbjR63itm7aXou-KwMuDQIrfZ5cnPWI2bhgguDhnzRhrOGNKNQV9vUdNijkn5-9sGNU3WeiShb7NQrOb0V7tccgj11dxTqFc4n_ss7_XuBP-HVQBXhwAyAYGnyAYzH84KVohWlq453tug-vND0xOF3cNYLSQxVdLylTzC1VxqsQ</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>CARMAN, Robert J</creator><creator>BOONE, James H</creator><creator>GROVER, Harish</creator><creator>WICKHAM, Kimberly N</creator><creator>LI CHEN</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20121101</creationdate><title>In Vivo Selection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy</title><author>CARMAN, Robert J ; BOONE, James H ; GROVER, Harish ; WICKHAM, Kimberly N ; LI CHEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a475t-33adea5c12026a6cdf66236a2418fcbd8a8d7e9df19637f8170bd6e596bf49d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Anti-Bacterial Agents</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial Proteins</topic><topic>Bacterial Proteins - genetics</topic><topic>Bacterial Proteins - metabolism</topic><topic>Biological and medical sciences</topic><topic>Clostridium difficile</topic><topic>Clostridium difficile - drug effects</topic><topic>Clostridium difficile - genetics</topic><topic>Clostridium difficile - pathogenicity</topic><topic>Drug Resistance, Bacterial</topic><topic>Drug Resistance, Bacterial - drug effects</topic><topic>Drug Resistance, Bacterial - genetics</topic><topic>Enterocolitis, Pseudomembranous - drug therapy</topic><topic>Enterocolitis, Pseudomembranous - microbiology</topic><topic>Epidemiology and Surveillance</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Other diseases. Semiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Rifamycins</topic><topic>Rifamycins - pharmacology</topic><topic>Rifamycins - therapeutic use</topic><topic>Selection, Genetic</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CARMAN, Robert J</creatorcontrib><creatorcontrib>BOONE, James H</creatorcontrib><creatorcontrib>GROVER, Harish</creatorcontrib><creatorcontrib>WICKHAM, Kimberly N</creatorcontrib><creatorcontrib>LI CHEN</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CARMAN, Robert J</au><au>BOONE, James H</au><au>GROVER, Harish</au><au>WICKHAM, Kimberly N</au><au>LI CHEN</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vivo Selection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>56</volume><issue>11</issue><spage>6019</spage><epage>6020</epage><pages>6019-6020</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>22908175</pmid><doi>10.1128/AAC.00974-12</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.6019-6020 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_highwire_asm_aac_56_11_6019 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Aged Anti-Bacterial Agents Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial Proteins Bacterial Proteins - genetics Bacterial Proteins - metabolism Biological and medical sciences Clostridium difficile Clostridium difficile - drug effects Clostridium difficile - genetics Clostridium difficile - pathogenicity Drug Resistance, Bacterial Drug Resistance, Bacterial - drug effects Drug Resistance, Bacterial - genetics Enterocolitis, Pseudomembranous - drug therapy Enterocolitis, Pseudomembranous - microbiology Epidemiology and Surveillance Gastroenterology. Liver. Pancreas. Abdomen Humans Male Medical sciences Microbial Sensitivity Tests Other diseases. Semiology Pharmacology. Drug treatments Polymorphism, Single Nucleotide Rifamycins Rifamycins - pharmacology Rifamycins - therapeutic use Selection, Genetic Stomach. Duodenum. Small intestine. Colon. Rectum. Anus |
| title | In Vivo Selection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T14%3A35%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vivo%20Selection%20of%20Rifamycin-Resistant%20Clostridium%20difficile%20during%20Rifaximin%20Therapy&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=CARMAN,%20Robert%20J&rft.date=2012-11-01&rft.volume=56&rft.issue=11&rft.spage=6019&rft.epage=6020&rft.pages=6019-6020&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.00974-12&rft_dat=%3Cproquest_highw%3E1113211993%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1113211993&rft_id=info:pmid/22908175&rfr_iscdi=true |